论文部分内容阅读
可溶性人白细胞抗原(sHLA)Ⅰ在体内参与免疫应答,可诱导产生免疫耐受,抑制细胞毒性T淋巴细胞(CTL)的溶细胞作用。在器官组织移植、感染性疾病、自身免疫性疾病及肿瘤分化中具有重要的免疫调节作用。
Soluble human leukocyte antigen (sHLA) I participates in the immune response in vivo and can induce immune tolerance and inhibit the cytolytic effect of cytotoxic T lymphocytes (CTLs). In organ transplantation, infectious diseases, autoimmune diseases and tumor differentiation has important immunomodulatory effects.